Navigation Links
Join Merrill DataSite's Webinar: The Impact of Financial Regulation on M&A in 2013

New York (PRWEB) May 06, 2013

Wednesday, 15th May 2013 | 10 a.m. BST | 5 p.m. HKT
Duration: 60 minutes

Register to join the live webinar here:

Ongoing regulatory changes are likely to touch every corner of the financial markets. Across the globe and particularly in Europe, a number of these new regulatory regimes will very probably affect M&A activity. For dealmakers, understanding how the likes of Basel iii, Solvency II, the AIFM directive and the ‘Tobin Tax’ affects the corner of the market will give a competitive edge and allow to shape the strategy accordingly.

Topics for discussion:

  •     What is the status of the most pertinent impending regulatory changes?
  •     Which of these changes will have a direct effect on the M&A market?
  •     Which of these will have unintended ‘knock-on’ effects?
  •     We are supposedly seeing greater global cooperation on financial regulation. Is this truly the case and is this beneficial to the M&A market?
  •     What should governments and lawmakers potentially do to ensure M&A activity is not hindered?
  •     What can M&A market players do to ensure they are prepared for regulatory changes?

About Merrill DataSite
Merrill DataSite is a secure virtual data room (VDR) solution that optimises the due diligence process by providing a highly efficient and secure method for sharing key business information between multiple parties. Merrill DataSite provides unlimited access for users worldwide, as well as real-time activity reports, site-wide search at the document level, enhanced communications through the Q&A feature and superior project management service - all of which help reduce transaction time and expense. Merrill DataSite’s multilingual support staff is available from anywhere in the world, 24/7/365, and can have your VDR up and running with thousands of pages loaded within 24 hours or less.

With its deep roots in transaction and compliance services, Merrill Corporation has a cultural, organisation-wide discipline in the management and processing of confidential content. Merrill DataSite is the first VDR provider to understand customer and industry needs by earning an ISO/IEC 27001:2005 certificate of registration – the highest standard for information security – and is currently the world’s only VDR certified for operations in the Europe, United States and Asia.

As the leading provider of VDR solutions, Merrill DataSite has empowered more than two million unique visitors to perform electronic due diligence on thousands of transaction totalling trillions of dollars in asset value. Merrill DataSite VDR solution has become an essential tool in an efficient and legally defensible process for completing multiple types of financial transactions.

For more information, please contact Merrill DataSite: Tel: +44 (0)845 602 6916;
Email: info(at)datasite(dot)com.

Register to access the webinar here:
Follow us on Twitter: @merrilldatasite

Read the full story at

Source: PRWeb
Copyright©2012 Vocus, Inc.
All rights reserved

Related medicine news :

1. Merrill DataSite Releases New Industry Insight on Jan 28th: 2012 M&A Review
2. Merrill DataSite Announces a New Article "Due Diligence Tips for SMEs Looking for Venture Capital" on its Website
3. Register to Access Merrill DataSite's Webcast Recording: M&A Financing Trends 2013: Accessing takeover financing in the year ahead
4. Merrill DataSite Releases New Comments: The Effect of Regulatory Reviews on US Financial M&A
5. Register to download Merrill DataSite's report: Monthly M&A Insider, March 2013
6. Register to Join Merrill DataSite's Live Webinar: The Impact of Financial Regulation on M&A in 2013
7. Merrill DataSite Releases New Comments: Solar technology M&A financing seeing shift in strategy
8. United Benefit Advisors Webinar: Private Lessons from The Public Sector, Strategies for Controlling Health Care Cost
9. Autism by the numbers: Yale researchers examine impact of new diagnostic criteria
10. Social ties have mixed impact on encouraging healthy behaviors in low-income areas
11. Pediatric epilepsy impacts sleep for the child and parents
Post Your Comments:
(Date:6/25/2016)... Long Beach, CA (PRWEB) , ... June 25, 2016 , ... ... from UCLA with Magna Cum Laude and his M.D from the David Geffen School ... San Diego and returned to Los Angeles to complete his fellowship in hematology/oncology at ...
(Date:6/25/2016)... ... ... On Friday, June 10, Van Mitchell, Secretary of the Maryland Department of ... recognition of their exemplary accomplishments in worksite health promotion. , The Wellness at Work ... Symposium at the BWI Marriott in Linthicum Heights. iHire was one of 42 businesses ...
(Date:6/24/2016)... ... 2016 , ... A recent article published June 14 on E ... goes on to state that individuals are now more comfortable seeking to undergo not ... as calf and cheek reduction. The Los Angeles area medical group, Beverly Hills Physicians ...
(Date:6/24/2016)... Marne, Michigan (PRWEB) , ... June 24, 2016 , ... ... awareness about the dangers associated with chronic pain and the benefits of holistic treatments, ... for individuals who are suffering with Sickle Cell Disease. , Sickle Cell Disease (SCD) ...
(Date:6/24/2016)... ... 24, 2016 , ... The Pulmonary Hypertension Association (PHA) learned ... receive two significant new grants to support its work to advance research and ... by recognizing patients, medical professionals and scientists for their work in fighting pulmonary ...
Breaking Medicine News(10 mins):
(Date:6/24/2016)... 2016  Arkis BioSciences, a leading innovator in ... durable cerebrospinal fluid treatments, today announced it has ... is led by Innova Memphis, followed by Angel ... investors.  Arkis, new financing will accelerate the commercialization ... release of its in-licensed Endexo® technology. ...
(Date:6/23/2016)... , June 23, 2016 Research ... "Pharmaceutical Excipients Market by Type (Organic Chemical (Sugar, Petrochemical, ... (Oral, Topical, Coating, Parenteral) - Global Forecast to 2021" ... The global pharmaceutical excipients market is ... a CAGR of 6.1% in the forecast period 2016 ...
(Date:6/23/2016)... Capricor Therapeutics, Inc. ... company focused on the discovery, development and commercialization ... in its ongoing randomized HOPE-Duchenne clinical trial (Halt ... its 24-patient target. Capricor expects the trial to ... 2016, and to report top line data from ...
Breaking Medicine Technology: